The phosphodiesterase 5 inhibitor sildenafil has no effect on cerebral blood flow or blood velocity, but nevertheless induces headache in healthy subjects
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
The phosphodiesterase 5 inhibitor sildenafil has no effect on cerebral blood flow or blood velocity, but nevertheless induces headache in healthy subjects. / Kruuse, Christina; Thomsen, Lars Lykke; Jacobsen, Torsten Bjørn; Olesen, Jes.
In: Journal of Cerebral Blood Flow and Metabolism, Vol. 22, No. 9, 09.2002, p. 1124-31.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - The phosphodiesterase 5 inhibitor sildenafil has no effect on cerebral blood flow or blood velocity, but nevertheless induces headache in healthy subjects
AU - Kruuse, Christina
AU - Thomsen, Lars Lykke
AU - Jacobsen, Torsten Bjørn
AU - Olesen, Jes
PY - 2002/9
Y1 - 2002/9
N2 - Cyclic nucleotides are important hemodynamic regulators in many tissues. Glyceryl trinitrate markedly dilates large cerebral arteries and increases cGMP. Here, the authors study the effect of sildenafil, a selective inhibitor of cGMP-hydrolyzing phosphodiesterase 5 on cerebral hemodynamics and headache induction. Ten healthy subjects were included in a double-blind, placebo-controlled crossover study where placebo or sildenafil 100 mg (highest therapeutic dose) were administered on two separate days. Blood velocity in the middle cerebral artery (Vmca) was recorded by transcranial Doppler, and regional cerebral blood flow in the perfusion area of the middle cerebral artery (rCBFmca) was measured using single photon emission computed tomography and xenon inhalation. Radial and temporal artery diameters were studied using high-frequency ultrasound. Blood pressure and heart rate were recorded repeatedly. Headache responses and tenderness of pericranial muscles were scored verbally. Sildenafil caused no significant changes in rCBFmca, Vmca, or in temporal or radial artery diameter, but heart rate increased and diastolic blood pressure decreased significantly compared to placebo. Despite the lack of cerebral arterial dilatation, sildenafil caused significantly more headache than placebo. The present results show that sildenafil 100 mg does not dilate cerebral or extracerebral arteries but nevertheless causes headache, which may be attributed to nonvascular mechanisms.
AB - Cyclic nucleotides are important hemodynamic regulators in many tissues. Glyceryl trinitrate markedly dilates large cerebral arteries and increases cGMP. Here, the authors study the effect of sildenafil, a selective inhibitor of cGMP-hydrolyzing phosphodiesterase 5 on cerebral hemodynamics and headache induction. Ten healthy subjects were included in a double-blind, placebo-controlled crossover study where placebo or sildenafil 100 mg (highest therapeutic dose) were administered on two separate days. Blood velocity in the middle cerebral artery (Vmca) was recorded by transcranial Doppler, and regional cerebral blood flow in the perfusion area of the middle cerebral artery (rCBFmca) was measured using single photon emission computed tomography and xenon inhalation. Radial and temporal artery diameters were studied using high-frequency ultrasound. Blood pressure and heart rate were recorded repeatedly. Headache responses and tenderness of pericranial muscles were scored verbally. Sildenafil caused no significant changes in rCBFmca, Vmca, or in temporal or radial artery diameter, but heart rate increased and diastolic blood pressure decreased significantly compared to placebo. Despite the lack of cerebral arterial dilatation, sildenafil caused significantly more headache than placebo. The present results show that sildenafil 100 mg does not dilate cerebral or extracerebral arteries but nevertheless causes headache, which may be attributed to nonvascular mechanisms.
KW - 3',5'-Cyclic-GMP Phosphodiesterases
KW - Adult
KW - Brain
KW - Cerebral Arteries
KW - Cerebrovascular Circulation
KW - Cyclic Nucleotide Phosphodiesterases, Type 5
KW - Double-Blind Method
KW - Female
KW - Headache
KW - Hemodynamics
KW - Humans
KW - Male
KW - Muscle, Skeletal
KW - Pain
KW - Papaverine
KW - Phosphodiesterase Inhibitors
KW - Phosphoric Diester Hydrolases
KW - Piperazines
KW - Purines
KW - Reference Values
KW - Sulfones
KW - Time Factors
KW - Ultrasonography, Doppler, Transcranial
KW - Vasodilator Agents
U2 - 10.1097/00004647-200209000-00010
DO - 10.1097/00004647-200209000-00010
M3 - Journal article
C2 - 12218418
VL - 22
SP - 1124
EP - 1131
JO - Journal of Cerebral Blood Flow and Metabolism
JF - Journal of Cerebral Blood Flow and Metabolism
SN - 0271-678X
IS - 9
ER -
ID: 136683273